Brady James Aloysius

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings

Download results Settings

Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2026-04-01	2026-03-30	Xeris Biopharma Holdings Inc (XERS)	PlS Planned sale	21,651 -35.5% 481.62 US$2,483,875	21,651 -35.5%	481.62	US$2,483,875
2026-03-30	2026-03-30	Xeris Biopharma Holdings Inc (XERS)	PrS Proposed sale	70,132 472.83 US$3,185,605	70,132	472.83	US$3,185,605
2025-08-05	2025-08-01	Verona Pharma PLC (VRNA)	S Sale	59,052 +42.0% 270.60 US$2,636,770	59,052 +42.0%	270.60	US$2,636,770